| abstract |
Processes for the preparation of dexlansoprazole, an amorphous form of dexlansoprazole, a solid dispersion of amorphous dexlansoprazole and a pharmaceutically acceptable carrier, and processes for its preparation. Compounds of crystalline 2 - [(R) - [(4-chloro-3-methyl-2-pyridinyl) methyl] sulfinyl] -1H-benzimide zol and 2 - [(R) - [(4-nitro-] are also provided. 3-methyl-2-pyridinyl) methyl] sulfin il] -1H-benzimidazole, and methods for its preparation. |